Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients. - Suppr | 超能文献

Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.

作者信息

Remberger M, Ringden O, Aschan J, Ljungman P, Lönnqvist B, Markling L

机构信息

Division of Clinical Immunology, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.

出版信息

Transplant Proc. 1994 Jun;26(3):1829-30.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.

Transplant Proc. 1994 Jun;26(3):1829-30.

2

Risk factors for acute graft-versus-host disease in 325 consecutive bone marrow recipients.325例连续骨髓移植受者急性移植物抗宿主病的危险因素

Transplant Proc. 1994 Jun;26(3):1821-2.

3

Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation.一项比较他克莫司（FK506）与环孢素预防异基因骨髓移植后移植物抗宿主病的III期研究。

Bone Marrow Transplant. 2001 Jul;28(2):181-5. doi: 10.1038/sj.bmt.1703097.

4

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.抗胸腺细胞球蛋白可预防慢性移植物抗宿主病、慢性肺功能障碍及移植相关晚期死亡率：无关供体移植患者随机试验的长期随访

Biol Blood Marrow Transplant. 2006 May;12(5):560-5. doi: 10.1016/j.bbmt.2005.12.034.

5

Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.使用供体淋巴细胞进行异基因细胞介导的免疫疗法，以预防接受异基因骨髓移植治疗血液系统恶性肿瘤的患者复发。

Clin Transpl. 1996:281-90.

6

A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.不同剂量静脉注射免疫球蛋白预防异基因骨髓移植后移植物抗宿主病和感染的多中心、随机、双盲比较

Bone Marrow Transplant. 2001 Jul;28(2):187-96. doi: 10.1038/sj.bmt.1703109.

7

Prevention of graft-versus-host disease on an individual basis.个体化预防移植物抗宿主病。

Transplant Proc. 1994 Jun;26(3):1823-4.

8

The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.部分T细胞清除对标准风险成年白血病患者接受人类白细胞抗原（HLA）匹配的异基因骨髓移植后的总体移植相关毒性、移植物功能及生存的影响

Bone Marrow Transplant. 2001 Nov;28(10):917-22. doi: 10.1038/sj.bmt.1703268.

9

A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial.一种使用抗CD6单克隆抗体偶联磁珠的新型骨髓T细胞清除方法及其在异基因骨髓移植中预防急性移植物抗宿主病的临床应用：一项I-II期试验结果

Int J Hematol. 1999 Jan;69(1):27-35.

10

Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.白血病骨髓移植受者长期生存的预后因素，特别强调年龄及移植物抗宿主病的预防

Clin Transplant. 1994 Jun;8(3 Pt 1):258-70.

引用本文的文献

1

The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后移植物抗白血病和移植物抗宿主病的微妙平衡。

Expert Rev Hematol. 2023 Jul-Dec;16(12):943-962. doi: 10.1080/17474086.2023.2273847. Epub 2023 Dec 18.

2

Immune recovery after allogeneic hematopoietic stem cell transplantation: is it time to revisit how patients are monitored?异基因造血干细胞移植后的免疫恢复：是时候重新审视如何监测患者了吗？

Biol Blood Marrow Transplant. 2012 Nov;18(11):1617-9. doi: 10.1016/j.bbmt.2012.09.007. Epub 2012 Sep 27.